Skip to main content
Screener/Healthcare/Biotechnology

DNLI — Denali Therapeutics Inc.

NASDAQ
$22.92-0.49 (-2.09%)
Mid CapUnder $50Healthcare
$12.58
$27.30
$22.64
$23.65
EPS (TTM)$-2.88
P/E Ratio-6.87
Dividend Yield—
Market Cap$3.78B
Volume578K
Prev Close$23.42
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$128.4M$-0.69——
Q4 '25$0-$128.5M$-0.73——
Q3 '25$0-$126.9M$-0.74——
Q2 '25$0-$124.1M$-0.72——
Q1 '25$0-$133.0M$-0.78——
Q4 '24$0-$114.8M$-0.67——
Q3 '24$0-$107.2M$-0.63——
Q2 '24$0-$99.0M$-0.59——
Get Your Daily Market Recap